首页> 外文期刊>Retinal cases & brief reports >CHOROIDAL INFARCTION AFTER PHOTODYNAMIC THERAPY COMBINED WITH BEVACIZUMAB AND TRIAMCINOLONE REVERSED BY TISSUE PLASMINOGEN ACTIVATOR: CASE REPORT
【24h】

CHOROIDAL INFARCTION AFTER PHOTODYNAMIC THERAPY COMBINED WITH BEVACIZUMAB AND TRIAMCINOLONE REVERSED BY TISSUE PLASMINOGEN ACTIVATOR: CASE REPORT

机译:组织纤溶酶原激活剂逆转贝伐单抗和三苯甲基噻吩并进行光动力治疗后发生的胆汁梗阻:病例报告

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: To present a case of choroidal infarction after combined therapy of photodynamic therapy, intravitreal bevacizumab, and sub-Tenon triamcinolone injection salvaged by tissue plasminogen activator administration.Methods: Interventional case report.Results: Combined therapy of full-fluence photodynamic therapy, intravitreal bevacizumab, and sub-Tenon triamcinolone injection was given on the same day to treat neovascular age-related macular degeneration in an 82-year-old patient. Subsequent acute visual loss and marked macular edema as a result of choroidal infarction were noted. Intravitreal and sub-Tenon administration of tissue plasminogen activator were performed 9 days later to salvage the choroidal infarction, and visual improvement was noted. Fundoscopy and optical coherent tomography showed almost complete resolution of macular edema. Indocyanine green angiography revealed reperfusion of the choroidal vessels.Conclusion: Choroidal infarction may happen after combined therapy. Tissue plasminogen activator administration may reverse the infarction and help visual recovery.
机译:目的:介绍光动力疗法,玻璃体内贝伐单抗联合组织纤溶酶原激活剂挽救的特农曲安奈德注射液联合治疗后的脉络膜梗死一例方法:介入性病例报告结果:全通量光动力疗法联合玻璃体内注射在同一天给予贝伐单抗和Tenon曲安奈德注射液治疗82岁患者的新血管性年龄相关性黄斑变性。注意到由于脉络膜梗塞而导致的随后的急性视力丧失和明显的黄斑水肿。 9天后进行玻璃体内和肌腱下给予组织纤溶酶原激活剂以挽救脉络膜梗塞,并观察到视觉改善。眼底镜检查和光学相干断层扫描显示黄斑水肿几乎完全消失。吲哚菁绿血管造影显示脉络膜血管再灌注。结论:联合治疗后可能发生脉络膜梗塞。组织纤溶酶原激活剂的给药可以逆转梗塞并帮助视觉恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号